Large scale analysis of genes contributing to the herbal preparation dependent hippocampal plasticity in postischemic rehabilitation

Vascular Pharmacology

Volumn 47, Issue 5-6, 2007, Pages 319-327

  Wang, Zhong ^a   Du, Qingyou ^b   Wang, Fusheng ^b   Xu, Qiuping ^c   Liu, Zhongrong ^d   Li, Baigang ^d   Wang, Anmin ^e   Wang, Yongyan ^a  

^a INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^b BEIJING 302 HOSPITAL   (China)

^c BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^d Chengdu Di'ao Pharmaceutical Group Co Ltd   (China)

^e INSTITUTE OF CHINESE MATERIA MEDICA   (China)

Author keywords

Brain plasticity; cDNA microarray; Cerebral ischemia reperfusion; Herbal therapy; Reorganization; Stroke rehabilitation

Indexed keywords

BETA ARRESTIN; HERBACEOUS AGENT; PROTEIN 14 3 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; DNA MICROARRAY; DRUG MECHANISM; GENE CONTROL; GENE EXPRESSION; HIPPOCAMPUS; MALE; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STROKE; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION REGULATION;

ANIMALS; BRAIN INFARCTION; BRAIN ISCHEMIA; DIOSGENIN; DRUGS, CHINESE HERBAL; FLAVANONES; GENE EXPRESSION PROFILING; HIPPOCAMPUS; MICE; NEURONAL PLASTICITY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STROKE;

EID: 35548933799     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2007.09.002     Document Type: Article

References (53)

1. Andres C., Osef T.K., and Julia M.U. Association of GABAB receptors and members of the 14-3-3 family of signaling proteins. Mol. Cell. Neurosci. 17 (2001) 317-328
2. Arriza J.L., Dawson T.M., Simerly R.B., Martin L.J., Caron M.G., Snyder S.H., and Lefkowitz R.J. The G-protein-coupled receptor kinases β-ARK1 and β-ARK2 are widely distributed at synapses in rat brain. J. Neurosci. 12 (1992) 4045-4055
3. Ashburner M., Ball C.A., Blake J.A., Botstein D., Butler H.J., Cherry J.M., Davis A.P., Dolinski K., Dwight S.S., Eppig J.T., Harris M.A., Hill D.P., Issel-Tarver L., Kasarskis A., Lewis S., Matese J.C., Richardson J.E., Ringwald M., Rubin G.M., and Sherlock G. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25 (2000) 25-29
4. Bergado-Rosado J.A., and Almaguer-Melian W. Cellular mechanisms of neuroplasticity. Rev. Neurol. 31 11 (2000) 1074-1095
5. Bracewell R.M. Stroke: neuroplasticity and recent approaches to rehabilitation. J. Neurol. Neurosurg. Psychiatry 74 (2003) 1465
6. Brazma A., Hingamp P., Quackenbush J., Sherlock G., Spellman P., Stoeckert C., Aach J., Ansorge W., Ball C.A., Causton H.C., Gaasterland T., Glenisson P., Holstege F.C.P., Kim I.F., Markowitz V., Matese J.C., Parkinson H., Robinson A., Sarkans U., Schulze-Kremer S., Stewart J., Taylor R., Vilo J., and Vingron M. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat. Genet. 29 (2001) 365-371
7. Bütefisch C.M. Plasticity in the human cerebral cortex: lessons from the normal brain and from stroke. Neuroscientist 10 (2004) 163-173
8. Byl N. Effectiveness of sensory and motor rehabilitation of the upper limb following the principles of neuroplasticity: patients stable post stroke. Neurorehabil. Neural Repair 17 (2003) 176-191
9. Cammarota M., Bevilaqua L.R., Viola H., Kerr D.S., Reichmann B., Teixeira V., Bulla M., Izquierdo I., and Medina J.H. Participation of CaMKII in neuronal plasticity and memory formation. Cell. Mol. Neurobiol. 22 3 (2002) 259-267
10. Chen J., Li Y., Wang L., Zhang Z., Lu D., Lu M., and Chopp M. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 32 (2001) 1005-1012
11. Couvert P., Bienvenu T., Aquaviva C., Poirier K., Moraine C., Gendrot C., Verloes A., Andrès C., Fevre A.C.L., Souville I., Steffann J., Portes V., Ropers H.H., Yntema H.G., Fryns J.P., Briault S., Chelly J., and Cherif B. MECP2 is highly mutated in X-linked mental retardation. Hum. Mol. Genet. 10 (2001) 941-946
12. DeFea K.A., Zalevsky J., Thoma M.S., Dery O., Mullins R.D., and Bunnett N.W. β-Arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular β-targeting of activated ERK1/2. J. Cell Biol. 148 (2000) 1267-1281
13. Elbert T., and Rockstroh B. Reorganization of human cerebral cortex: the range of changes following use and injury. Neuroscientist 10 2 (2004) 129-141
14. Feeney D.M. Rehabilitation pharmacology: noradrenergic enhancement of physical therapy. In: Ginsberg M.D., and Bogousslavsky J. (Eds). Cerebrovascular Disease: Pathophysiology, Diagnosis and Management (1998), Blackwell Science, Oxford, UK 620-636
15. Feeney D.M., and Sutton R.L. Pharmacotherapy for recovery of function after brain injury. Crit. Rev. Neurobiol. 3 (1987) 135-197
16. Fernando G.P., Ying Z., Roy R.R., Molteni R., and Edgerton V.R. Voluntary exercise induces a BDNF-mediated mechanism that promotes neuroplasticity. J. Neurophysiol. 88 (2002) 2187-2195
17. Gagliardini V., Dusart I., and Fankhauser C. Absence of GAP-43 can protect neurons from death. Mol. Cell. Neurosci. 16 (2000) 27-33
18. Garber K. Big plans for small molecules: NIH launches chemical initiative. J. Natl. Cancer Inst. 95 23 (2003) 1740-1741
19. Giaever G., Flaherty P., Kumm J., Proctor M., Nislow C., Jaramillo D.F., Chu A.M., Jordan M.I., Arkin A.P., and Davis R.W. Chemogenomic profiling: identifying the functional interactions of small molecules in yeast. PNAS 101 3 (2004) 793-798
20. Goldstein L.B. Basic and clinical studies on pharmacologic effects on recovery from brain injury. J. Neural Transpl. Plast. 4 (1993) 174-192
21. Goldstein L.B. Potential effects of common drugs on stroke recovery. Arch. Neurol. 55 (1998) 454-456
22. Grade C., Redford B., Chrostowski J., Toussaint L., and Blackwell B. Methylphenidate in early post stroke recovery: a double-blind, placebo-controlled study. Arch. Phys. Med. Rehabil. 79 (1998) 1047-1050
23. Groth R.D., and Mermelstein P.G. Brain-derived neurotrophic factor activation of NFAT (Nuclear Factor of Activated T-Cells)-dependent transcription: a role for the transcription factor NFATc4 in neurotrophin-mediated gene expression. J. Neurosci. 23 (2003) 8125-8134
24. Jin K.L., Mao X.O., and Eshoo M.W. Microarray analysis of hippocampal gene expression in global cerebral ischemia. Ann. Neurol. 5 (2001) 93-103
25. Kawase M., Murakami K., Fujimura M., Morita-Fujimura Y., Gasche Y., Kondo T., Scott R.W., and Chan P.H. Exacerbation of delayed cell injury after transient global ischemia in mutant mice with CuZn superoxide dismutase deficiency. Stroke 30 (1999) 1962-1968
26. Keyvani K., Sachser N., Witte O.W., and Paulus W. Gene expression profiling in the intact and injured brain following environmental enrichment. J. Neuropathol. Exp. Neurol. 63 6 (2004) 598-609
27. Kumar A., Soprano D.R., and Parekh H.K. Cross-resistance to the synthetic retinoid CD437 in a paclitaxel-resistant human ovarian carcinoma cell line is independent of the overexpression of retinoic acid receptor. Cancer Res. 61 (2001) 7552-7555
28. Kyoungho S., Heasuk L., Sang S.K., Gyeong J.C., and Wan S.C. Flavonoid baicalein attenuates activation-induced cell death of brain microglia. J. Pharmacol. Exp. Ther. 305 (2003) 638-645
29. Landers M. Treatment-induced neuroplasticity following focal injury to the motor cortex. Int. J. Rehabil. Res. 27 1 (2004) 1-5
30. Lee C.K., Weindruch R., and Prolla T.A. Gene-expression profile of the ageing brain in mice. Nat. Genet. 25 (2000) 294-297
31. Lisman J., Schulman H., and Cline H. The molecular basis of CAMKII function in synaptic and behavioural memory. Nat. Rev., Neurosci. 3 (2002) 175
32. Luttrell L.M., Ferguson S.S., Daaka Y., Miller W.E., Maudsley S., Della R.G.J., Lin F., and Thierry D. From global expression data to gene networks. BioEs-survivalsays 21 (1999) 895-899
33. Macián F., Carmen G.R., and Rao A. Gene expression elicited by NFAT in the presence or absence of cooperative recruitment of Fos and Jun. EMBO J. 19 (2000) 4783-4795
34. Michal H., Eli-Berchoer L., Wapinski I., Friedman N., and Kodesh E. Stress-related genomic responses during the course of heat acclimation and its association with ischemic-reperfusion cross-tolerance. J. Appl. Physiol. 97 (2004) 1496-1507
35. Mirnics K., Middleton F.A., Lewis D.A., and Levitt P. Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse. Trends Neurosci. 8 (2001) 479-486
36. Nishino K., Sasaki T., Takahashi K., Chiba M., and Ito T. The norepinephrine precursor l-threo-3, 4-dihydroxyphenylserine facilitates motor recovery in chronic stroke patients. J. Clin. Neurosci. 8 (2001) 547-550
37. Patrick G.H., Chen L., Julie N., and Rao A. Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev. 17 (2003) 2205-2232
38. Scheidtmann K., Fries W., Muller F., and Koenig E. Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: a prospective, randomized, double-blind study. Lancet 358 (2001) 787-790
39. Shahbazian M.D., and Zoghbi H.Y. Molecular genetics of Rett syndrome and clinical spectrum of MECP2 mutations. Curr. Opin. Neurol. 14 (2001) 171-176
40. Shaw C.A., Lanius R.A., and van den Doel K. The origin of synaptic neuroplasticity: crucial molecules or a dynamic cascade?. Brain Res. Rev. 19 (1994) 241-263
41. Sheng M., and Kim M.J. Postsynaptic signaling and plasticity mechanisms. Science 298 (2002) 776-780
42. Soriano M.A., Tessier M., Certa U., and Gill R. Parallel gene expression monitoring using oligonucleotide probe arrays of multiple transcripts with an animal model of focal ischemia. J. Cereb. Blood Flow Metab. 20 (2000) 1045-1055
43. Stephen S.G.F. Evolving concepts in g protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol. Rev. 53 (2001) 1-24
44. Stephenson D., Yin T., and Smalstig E.B. Transcription factor nuclear factor-Kappa B is activated in neurons after focal cerebral ischemia. J. Cereb. Blood Flow Metab. 3 (2000) 592-603
45. Tanaka H., Calderone A., Jover T., Grooms S.Y., Yokota H., Zukin R.S., and Bennett M.V.L. Ischemic preconditioning acts upstream of GluR2 down-regulation to afford neuroprotection in the hippocampus CA1. PNAS 99 4 (2002) 2362-2367
46. Trendelenburg G., Prass K., Priller J., Kapinya K., Polley A., Muselmann C., Ruscher K., Kannbley U., Schmitt A.O., Castell S., Wiegand F., Meisel A., Rosenthal A., and Dirnagl U. Serial analysis of gene expression identifies metallothionein-II as major neuroprotective gene in mouse focal cerebral ischemia. J. Neurosci. 22 (2002) 5878-5888
47. Tusher V.G., Tibshirani R., and Chu G. Significance analysis of microarrays applied to the ionizing radiation response. PNAS 98 (2001) 5116-5121
48. Wang Z., Zhou J., Ju Y., Zhang H., Liu M., and Li X. Effects of two saponins extracted from the Polygonatum zanlanscianense pamp on the human leukemia (HL-60) cells. Biol. Pharm. Bull. 24 (2001) 159-162
49. Wang Z., Du Q., Wang F., Liu Z., Li B., Wang A., and Wang Y. Microarray analysis of genes expression on herbal glycoside recipes improving deficient ability of spatial learning memory in ischemic mice. J. Neurochem. 88 (2004) 1406-1415
50. Whitney L.W., Becker K.G., Tresser N.J., Caballero-Ramos C.I., Munson P.J., Prabhu V.V., Trent J.M., McFarland H.F., and Biddison W.E. Analysis of gene expression in multiple sclerosis lesions using cDNA microarrays. Ann. Neurol. 3 (1999) 425-428
51. Xia Z.Q., Gray J.A., Compton-Toth B.A., and Roth B.L. A direct interaction of PSD-95 with 5-HT2A serotonin receptors regulates receptor trafficking and signal transduction. J. Biol. Chem. 278 (2003) 21901-21908
52. Yasutake M., Kazunori I., and Taiichi K. Two cis-acting elements in the 3′untranslated region of α-CaMKII regulate its dendritic targeting. Nat. Neurosci. 11 (2000) 1079-1084
53. Zdraveski Z.Z., Mello J.A., Marinus M.G., and Essigmann J.M. Multiple pathways of recombination define cellular responses to cisplatin. Chem. Biol. 7 1 (2000) 39-50